Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03870997 · ClinicalTrials.gov registry record · NA

Influenza Vaccination Digital Interventions for People Living With Diabetes

A NA study, sponsored by Evidation Health.

Completed
Registry status
NA
Development phase
94,321
Enrollment target

NCT03870997: Completed NA study, sponsored by Evidation Health.

NCT03870997 is a NA study that has completed, run by Evidation Health. The registered enrollment target is 94,321 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (6628% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03870997, a NA study, has completed, sponsored by Evidation Health.

COMPLETED
Registry status
NA
Development phase
94,321 participants
Enrollment target

Study Summary

The overall objective of this prospective randomized controlled study is to assess and quantify the impact of digital interventions to increase vaccination rates and vaccination-related outcomes in a connected population with self-reported diabetes. The digital intervention will be delivered via a campaign sent to participants, with interventions varying with each study arm. Participants will be blinded to study participation status.

Primary Outcome

Number of participants with self-reported influenza vaccination in People With Diabetes: Intervention arm as compared to People With Diabetes: Control arm

Interventions

  • BEHAVIORAL Diabetes Digital Intervention
  • BEHAVIORAL Generic Digital Intervention

Trial Details

FieldValue
Enrollment Target 94,321 participants
Start Date 2018-09-12
Est. Completion 2019-04-08
Phase NA
Evidation Health

12 total trials

What the finished NCT03870997 record still lists

NCT03870997 is an interventional study that assigns participants to a tested intervention. Its 94,321 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (6628% higher).

The record links to 0 conditions, and to 2 interventions - of which Diabetes Digital Intervention is the first listed.

NCT03870997 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03870997 about?

NCT03870997 is a clinical study titled "Influenza Vaccination Digital Interventions for People Living With Diabetes". The overall objective of this prospective randomized controlled study is to assess and quantify the impact of digital interventions to increase vaccination rates and vaccination-related outcomes in a connected population with self-reported diabetes. The digital intervention will be delivered via a c...

What is the current status of trial NCT03870997?

This trial is currently completed. It is a NA study. The enrollment target is 94,321 participants. The study started on 2018-09-12. Estimated completion is 2019-04-08.

What interventions are being tested in trial NCT03870997?

The interventions under investigation include: Diabetes Digital Intervention (BEHAVIORAL), Generic Digital Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03870997?

This trial is sponsored by Evidation Health, which has 12 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03870997's enrollment target sits among peer trials

94,321 3rd of 2000 higher than 1,998 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01351545 · 99,999 participants

    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

  • NCT02620852 · 100,000 participants · NA

    Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

  • NCT03277365 · 100,000 participants · NA

    MyGeneRank: A Digital Platform for Next-Generation Genetic Studies

  • NCT04281823 · 100,000 participants

    DeBakey Cardiovascular Magnetic Resonance Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03870997, the US trial registry maintained by the National Library of Medicine. NCT03870997 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.